Page 19 - Gena Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood. If you want to skip our detailed analysis of Cathie Wood...

BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. BioCryst Pharmaceuticals (NASDAQ: BCRX) Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst's first-quarter 2021 earnings call. [Operator instructions] I would now like to hand the conference over to your speaker today, Mr. John Bluth of BioCryst. John, the floor is yours. John Bluth -- Senior Vice President, Investor Relations and Corporate Communications Thanks, Jay. Good morning and welcome to BioCr...

Operator Good morning. My name is Izzy and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] [Operator Instructions]. Following formal remarks, we will open the call up for questions. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. I will now turn the conference to Lina Li, Director of Investor Relations at Intellia. Please proceed. Lina Li -- Director, Investor Relations Thank you, operator. And Go...

Sarepta Therapeutics (SRPT) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Sarepta Therapeutics (NASDAQ: SRPT) Good afternoon, ladies and gentlemen, and welcome to the Sarepta Therapeutics first-quarter 2021 earnings call. [Operator instructions] As a reminder, today's program is being recorded. I'd now like to introduce your host for today's program, Mary Jenkins, senior management, investor relations. Please go ahead. Mary Jenkins -- Senior Management, Investor Relations Thank you, Jonathan, and thank ...

Operator Good afternoon, and welcome to the REGENXBIO First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer of REGENXBIO. You may begin. Patrick J. Christmas II, J.D. -- Chief Legal Officer Good afternoon, and thank you for joining us. With us today are Ken Mills, REGENXBIO's President and Chief Executive Officer; and Dr. Steve Pakola, our Chief Medical Officer. Earlier this afternoon, REGENXBIO released financial and operating results for...